10Elms LLP’s Colgate-Palmolive CL Stock Holding History

10Elms LLP’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-269	Closed	-$25.2K	–	506
2025 Q1	$25.2K	Hold	269	–	–	0.03%	311
2024 Q4	$24.5K	Buy	+269	New	+$25.7K	0.03%	311

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

10Elms LLP's CL Position: Q2 2025 in Review

10Elms LLP sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 269 shares — an estimated $25.2K sold.

10Elms LLP first reported a position in CL in Q4 2024 and held it in 2 quarters. The position peaked at $25.2K in Q1 2025. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

10Elms LLP reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
10Elms LLP sold 269 Colgate-Palmolive shares in Q2 2025, an estimated $25.2K.
10Elms LLP first reported a position in Colgate-Palmolive in Q4 2024 and held it in 2 quarters.
10Elms LLP's Colgate-Palmolive position peaked at $25.2K in Q1 2025.
1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on 10Elms LLP's 13F filing for Q2 2025, filed 14 Aug 2025.